22157.jpg
Global Gastric Cancer Forecast and Market Analysis Report 2020-2027 - Trastuzumab Biosimilars are Now Available, Leading to a Sharp Decline in the Market Share of Herceptin
January 28, 2021 06:33 ET | Research and Markets
Dublin, Jan. 28, 2021 (GLOBE NEWSWIRE) -- The "Gastric Cancer Forecast and Market Analysis" drug pipelines has been added to ResearchAndMarkets.com's offering. The report estimates that in 2018,...
AzurRx_Logo_CMYK.jpg
AzurRx BioPharma Announces $8.0 Million Offerings
January 04, 2021 07:00 ET | AzurRx BioPharma, Inc.
DELRAY BEACH, Fla., Jan. 04, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a company specializing in the development of non-systemic,...
22157.jpg
Global Checkpoint Inhibitors Market Report 2020-2030: COVID-19 Growth and Changes
December 22, 2020 05:23 ET | Research and Markets
Dublin, Dec. 22, 2020 (GLOBE NEWSWIRE) -- The "Checkpoint Inhibitors Global Market Report 2020-30: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering. ...
22157.jpg
Immune Checkpoint Inhibitors Market, 2025
October 30, 2020 04:53 ET | Research and Markets
Dublin, Oct. 30, 2020 (GLOBE NEWSWIRE) -- The "Immune Checkpoint Inhibitors Market - Growth, Trends, and Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. The...
22157.jpg
Global PD-1/PD-L1 Immunotherapy Market Analysis and Forecast, 2019-2020 & 2030
October 23, 2020 04:53 ET | Research and Markets
Dublin, Oct. 23, 2020 (GLOBE NEWSWIRE) -- The "Global PD-1/PD-L1 Immunotherapy Market: Focus on Type, Application, Country Data (14 Countries), and Competitive Landscape - Analysis and Forecast,...
22157.jpg
Global Immunotherapy in Oncology Startup Identification Report 2020: Over 110 Startups Working in the Field of Onco-Immunotherapy
September 15, 2020 05:43 ET | Research and Markets
Dublin, Sept. 15, 2020 (GLOBE NEWSWIRE) -- The "Immunotherapy in Oncology Startup Identification" report has been added to ResearchAndMarkets.com's offering. Cancer Immunotherapy is a very dynamic...